Loading LXRX charts…
May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy
Loading LXRX comparable companies…
| LXRXLexicon Pharmaceuticals, Inc.(opens in a new tab) | $0.63B | $0.04B | +24.1% | 99.1% | −131.4% | 15.09× | — |
|---|---|---|---|---|---|---|---|
| FLNAFilana Therapeutics, Inc.(opens in a new tab) | — | $0.04B | +277.6% | — | — | — | — |
| EQEquillium, Inc.(opens in a new tab) | $0.15B | $0.04B | +13.9% | — | — | — | — |
| CPIXCumberland Pharmaceuticals Inc.(opens in a new tab) | $0.07B | $0.04B | −5.2% | 82.9% | −24.1% | 1.78× | — |
| CUECue Biopharma, Inc.(opens in a new tab) | $0.13B | $0.04B | +354.4% | — | −262.0% | 3.48× | — |
| Medianpeers, excl. LXRX | $0.13B | $0.04B | +145.7% | 82.9% | −143.1% | 2.63× | — |